Toyota: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Aetna (AET) upgraded at BofA/Merrill to Neutral from Underperform as there is a more balanced risk reward. Price target lifted to $36 from $32. 2010 and 2011 EPS estimates set at $2.60 and $3.14, respectively.

The Buckle (BKE) upgraded at Susquehanna from Neutral to Positive. $43 price target. Estimates also raised, as the company has room to grow in its potential niche.

Cheesecake Factory (CAKE) downgraded at MKM from Buy to Neutral. Valuation call, as the stock has run in recent months.

Cigna (CI) downgraded at BofA/Merrill to Underperform from Neutral. More upside elsewhere in the space. $38 price target.

Comerica(CMA) estimates, target raised at FBR. CMA estimates were increased through 2011. Company should benefit from the TARP repayment. Market Perform rating and new $35 price target.

Comerica (CMA) downgraded at BMO to Market Perform. $35 price target. New capital raise carries significant dilution.

Health Net (HNT) upgraded at BMO to Market Perform. Tricare protest should end in the company's favor. $24 price target.

Henry Schein (HSIC) rated new Neutral at UBS. Stock is pricing in a recovery in the U.S. dental market. Slowdown in Europe could also limit earnings upside.

Jacobs Engineering (JEC) upgraded at BofA/Merrill to Buy from Neutral. Lower risk play on capex. Price target surged to $50 from $44.

KC Southern (KSU) rated new Equal-weight at Morgan Stanley. Expect double-digit growth in rail volumes for 2010.

Owens & Minor (OMI) rated new Neutral at UBS. Company is growing through acquisitions, but activity in surgical procedures remains sluggish.

Patterson (PDCO) rated new Neutral at UBS. Stock is already discounting a recovery in domestic dental spending.

Toyota (TM) downgraded at Standpoint from Buy to Hold. Stock should be sold into the recent bounce.

URS (URS) downgraded at BofA/Merrill to Underperform from Buy as defensive model drives less upside. Price target lowered to $53 from $55.

Warnaco Group (WRC) target boosted at Morgan Stanley. Shares of WRC now seen reaching $48. Company is seeing better retail margins. Equal-weight rating.